Take Solutions Limited (TAKE) fundamentals
Take Solutions Limited is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as TAKE (ISIN INE142I01023). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Take Solutions Limited does
Take Solutions Limited is an India-based contract research organization (CRO), which is engaged in supporting pharma, biotech and devices companies. The Company offers clients a combination of full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry network forums. Its digital healthcare services include medical decision-making (artificial intelligence and machine learning), and cloud adoption & mobility. Its global roster of clients includes large and small biopharmaceutical and device companies, United States federal agencies like Centers for Disease Control and Prevention (CDC) and the United States Department of Defense (DoD), as well as generics manufacturers. The Company's subsidiary is Ecron Acunova Limited.
Valuation and market data
| Last close | ₹16.78 |
|---|---|
| Market capitalisation | ₹5 crore |
| Enterprise value | ₹1 crore |
| P/E (TTM) | 0.00 |
| Price to book | 0.24 |
| Price to sales (TTM) | 0.05 |
| Book value per share | ₹71.01 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Mon Aug 27 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹7 crore | ₹3 crore | ₹3 crore | 0.00 |
| Mar 2025 | ₹14 crore | ₹10 crore | ₹10 crore | -4.72 |
| Mar 2024 | ₹6 crore | ₹-71 crore | ₹-75 crore | -14.01 |
| Mar 2023 | ₹65 crore | ₹5 crore | ₹4 crore | 0.29 |
| Mar 2022 | ₹35 crore | ₹-3 crore | ₹-5 crore | -32.26 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 0.0% |
|---|---|
| Foreign institutions (FII) | 0.2% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 99.8% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.